Pensatech Pharma GmbH (founded in 2012) is an innovative drug delivery company offering: 

1) Advanced drug formulation and analytical services

2) Novel drug products and difficult-to-formulate generics developed in-house for partnering or out-licensing.

1) Services/ Technologies 

• Oral modified release 

  • Enteric, extended, pulsatile, colonic, high dose, FDC

  • Pellets, minitablets, tablets, matrix and reservoir systems

• Long acting injectables (LAI)

  • Microparticles, implants, in-situ implants, suspensions,

  • Carriers: biodegradable (poly(lactide-co-glycolide)) and non-degradable(PEVA) polymers and lipids

• Bioavailablity enhancement 

  • Nanosuspensions, ASD, solubilisation

• Nanocarriers (nanoparticles, nanocrystals, liposomes)

• Local delivery (ophthalmic, topical, nasal, buccal)

• Paediatric/ geriatric formulations

• Stability improvement

• Taste-masking

• Processes include: 

  • Tabletting, coating, milling, hot melt extrusion (HME), lyophilization, microencapsulation, spray drying 

• APIs: 

  • Small APIs, peptide-/protein-/ oligonucleotide-APIs, highly potent APIs, cytotoxics, controlled substances

We support you with: 

• Preformulation

• Formulation and Process Development

• Analytical Development

• Stability Studies

• EU GMP Quality Control & Batch Certification

2) Summary Products

2a) In House Developments

• GLP-1: 

  • Long Acting Injectables 

• Triptorelin: 

  • Long Acting Injectables (upto 1 year) 

• Ophthalmic: 

  • Dry eye disease (DED)

  • Post-Cataract Inflammation

  • Cataract & Presbiopia

  • Cystinosis 

• Cannabinoids (THC, CBD and others)

  • Novel Dosage Forms

• Dermal Fillers 

2b) Generic Developments

• Budesonid (Budenofalk®):

  • Oral Modified Release Pellets (3, 9 mg)

• Triptorelin (Decapeptyl®, Pamorelin®): 

  • Biodegradable Microparticles (1, 3, 6 months) 

• Dexamethasone (Ozurdex®): 

  • Biodegradable Intravitreal Implant 

• Moxidectin (Proheart®): 

  • Lipid Microparticles (Animal Health)